Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L de Heide

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|December 12, 1987
[Infectious mononucleosis, different from the usual]L de Heide, B P Hazenberg
Magnesium Research|June 1, 1996
Oral physiological magnesium supplementation for 6 weeks with 1 g/d magnesium oxide does not affect increased Lp(a) levels in hypercholesterolaemic subjectsN Hoogerbrugge, C Cobbaert, L de Heide, et al.
Journal of Internal Medicine|February 1, 1997
The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemiaN Hoogerbrugge, H Jansen, L De Heide, et al.
Journal of Internal Medicine|July 4, 1998
The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemiaN Hoogerbrugge, H Jansen, L De Heide, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|December 12, 1987
[Infectious mononucleosis, different from the usual]L de Heide, B P Hazenberg
Magnesium Research|June 1, 1996
Oral physiological magnesium supplementation for 6 weeks with 1 g/d magnesium oxide does not affect increased Lp(a) levels in hypercholesterolaemic subjectsN Hoogerbrugge, C Cobbaert, L de Heide, et al.
Journal of Internal Medicine|February 1, 1997
The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemiaN Hoogerbrugge, H Jansen, L De Heide, et al.
Journal of Internal Medicine|July 4, 1998
The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemiaN Hoogerbrugge, H Jansen, L De Heide, et al.
Pageof 1